☆ 4.3 Editorial Material

Microbial influencers: treating diabetes through the gut

IMMUNOLOGY AND CELL BIOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation

Kirstine J. Bell et al.

Summary: The study investigates the effects of HAMSAB supplementation on individuals with T1D. It finds that the supplement leads to changes in gut microbiota composition and function, as well as the immune profile, resulting in increased SCFA levels. These changes are associated with improved glycemic control.

MICROBIOME (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Collider Bias

Mathias J. Holmberg et al.

Summary: This JAMA Guide to Statistics and Methods explains collider bias, provides examples in directed acyclic graphs, and discusses how it can impact the internal validity of a study and accurate estimation of causal relationships in randomized clinical trials and observational studies.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Gut microbiome, prebiotics, intestinal permeability and diabetes complications

Matthew Snelson et al.

Summary: Changes in gut microbiota in diabetes can lead to decreased intestinal barrier function, affecting systemic inflammation and worsening microvascular diabetes complications. Prebiotics offer a dietary approach to increase beneficial short chain fatty acids produced by gut microbiota and improve intestinal permeability in diabetes.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells

Murat Tekguc et al.

Summary: Regulatory T cells reduce the expression of CD80/CD86 on antigen-presenting cells through CTLA-4-dependent trogocytosis, inhibiting T cell immune responses. This mechanism can have dual suppressive effects, limiting CD80/CD86 costimulation to naive T cells and increasing free PD-L1 available for the inhibition of PD-1-expressing effector T cells.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial

Dakota Rhys-Jones et al.

Summary: This study aims to investigate whether acetylated and butyrylated modified resistant starch can lower blood pressure of hypertensive individuals by modulating the gut microbiota and releasing high levels of SCFAs. The study is a phase IIa double-blinded, randomised, cross-over, placebo controlled trial, with the primary endpoint being a reduction in ambulatory daytime systolic blood pressure and secondary endpoints including changes to circulating cytokines, immune markers, and modulation to the gut microbiome.

TRIALS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

Pieter de Groot et al.

Summary: This study found that fecal microbiota transplantation can help delay disease progression and protect pancreatic function in patients with type 1 diabetes. Certain plasma metabolites and bacterial strains are associated with preserved residual beta cell function. The gut microbiome plays a crucial role in the pathophysiology of T1D.

GUT (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial

Pieter F. de Groot et al.

DIABETOLOGIA (2020)

添加到收藏夹

Article Agriculture, Multidisciplinary

Butyrate Ameliorates Antibiotic-Driven Type 1 Diabetes in the Female Offspring of Nonobese Diabetic Mice

Lingling Jia et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

Tommi Vatanen et al.

NATURE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study

Pieter F. de Groot et al.

PLOS ONE (2017)

添加到收藏夹

Article Immunology

Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes

Eliana Marino et al.

NATURE IMMUNOLOGY (2017)

添加到收藏夹

Article Endocrinology & Metabolism

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

Richard A. Oram et al.

DIABETES CARE (2016)

添加到收藏夹

Article Nutrition & Dietetics

Butyrate esterified to starch is released in the human gastrointestinal tract

Julie M. Clarke et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)

添加到收藏夹

Article Endocrinology & Metabolism

Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

Zhanguo Gao et al.

DIABETES (2009)

添加到收藏夹

Meeting Abstract Endocrinology & Metabolism

SIRT1 Knockout Leads to Angiogenesis Deficiency in Adipose Tissue through Macrophage Dysfunction

Fen Xu et al.

DIABETES (2009)

添加到收藏夹

Article Endocrinology & Metabolism

Marginal-zone B-Cells of Nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-Cells

Eliana Marino et al.

DIABETES (2008)

添加到收藏夹

Article Immunology

Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression

Cecilia Oderup et al.

IMMUNOLOGY (2006)

添加到收藏夹

Article Nutrition & Dietetics

Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats

G Annison et al.

JOURNAL OF NUTRITION (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.